Announcing a new article publication for BIO Integration journal. In this article the authors Daowei Lin, Zhixiao Han, Yanni Fu, Xiaoqiu Zhu, Jin Li, Hui Xu, Jing Wen, Fei Wang and Mingyan Guo from ...
Please provide your email address to receive an email when new articles are posted on . Use of liposomal bupivacaine in an interscalene nerve block effectively controlled pain after outpatient ...
— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor ...
TAMPA, Fla., March 29, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced ...
Please provide your email address to receive an email when new articles are posted on . According to published results, peripheral nerve blocks may effectively reduce postoperative pain in patients ...
TAMPA, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NSDQ: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
Prime Hospital Reiterates Commitment Enhancing Healthcare Sector with Ultrasound-Guided Nerve Blocks
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Prime Hospital, one of the UAE's leading healthcare service providers, has achieved another milestone by applying various innovative Anesthetic Techniques ...
The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for Exparel (bupivacaine liposome injectable suspension) to include both single-dose sciatic nerve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results